hypothesisbas
diagnosi
practis
least
three
millennia
leviticu
circa
bce
provid
detail
instruct
presumpt
diagnosi
leprosi
diagnost
process
explain
base
shape
color
lesion
durat
quarantin
specifi
reexamin
quarantin
recommend
treatment
describ
base
presumpt
diagnosi
presumpt
diagnosi
remain
crucial
triag
earli
correct
deduct
critic
patient
outcom
estim
million
dengu
infect
occur
annual
fatal
specif
treatment
dengu
appropri
medic
care
save
live
dengu
hemorrhag
fever
patient
abil
rapidli
identifi
etiolog
agent
clinic
immunolog
genet
factor
predict
diseas
sever
outcom
would
impact
significantli
capac
overburden
health
facil
manag
diseas
argument
appli
australian
bat
lyssaviru
hendra
nipah
virus
purifi
immunoglobulin
novel
engin
antibodi
therapeut
avail
case
astut
presumpt
diagnosi
critic
facilit
use
correct
therapeut
antibodi
appropri
public
health
intervent
earli
presumpt
diagnosi
inform
choic
antibacteri
antivir
antiprotozo
medic
howev
differenti
difficult
base
circumst
sign
symptom
eg
differenti
cyclic
fever
caus
streptococcu
pyogen
sever
possibl
arbovirus
malaria
hypothesisbas
ration
approach
diagnost
test
summar
follow
step
suspicion
base
sign
symptom
step
provision
step
choos
design
targetfocus
step
confirm
suspicion
return
step
ye
go
step
step
treat
step
communitywid
intervent
recent
molecular
diagnost
procedur
select
result
presumpt
diagnosi
nucleic
acidbas
test
develop
last
two
decad
remark
success
acceler
abil
identifi
etiolog
agent
howev
convent
approach
assay
design
limit
context
chang
diseas
environ
nucleic
acidbas
test
design
detect
singl
organ
small
panel
organ
chosen
basi
presumpt
diagnosi
standard
targetfocus
pcr
ligas
chain
reaction
even
moder
multiplex
test
fail
etiolog
agent
part
panel
test
usual
uncommon
viral
infect
common
immunocompromis
patient
novel
sequenc
variant
appear
variat
may
region
viru
target
probe
primer
novel
known
virus
emerg
unexpect
place
unforeseen
circumst
moreov
absenc
sequenc
inform
design
primer
andor
probe
new
test
detect
new
diseas
time
consum
time
new
probe
ad
suit
targetfocus
test
diseas
outbreak
may
run
cours
inde
mani
death
viral
enceph
uk
attribut
specif
etiolog
agent
evid
room
improv
present
opportun
broadspectrum
molecular
diagnost
narrowli
focus
basi
presumpt
diagnosi
factor
environ
potenti
influenc
spectrum
virus
homo
sapien
expos
summar
follow
section
potenti
impact
factor
targetfocus
nucleic
acidbas
diagnost
test
discuss
present
exampl
emerg
technolog
respons
virus
constitut
vast
reservoir
genet
divers
surveil
program
continu
discov
new
virus
nation
arboviru
monitor
program
northern
australia
sampl
hundr
sentinel
cattl
herd
fieldtrap
insect
thousand
virus
collect
cultur
store
identifi
pathogen
potenti
vast
major
remain
unknown
exampl
recent
work
area
applic
pcrselect
cdna
subtract
hybrid
character
sever
new
rhabdovirida
culicoid
spp
bite
midg
antibodi
one
virus
found
cattl
macropod
among
new
virus
discov
last
year
highli
pathogen
avian
influenza
hendranipah
sever
acut
respiratori
syndromeassoci
coronaviru
human
bocaviru
novel
human
parvovirus
human
polyomavirus
human
metapneumovirus
zoonot
human
tcell
lymphotrop
virus
htlv
herpesvirus
flavivirus
mention
later
articl
reason
suggest
climat
chang
impact
distribut
diseas
vector
virus
howev
geograph
direct
chang
local
impact
due
climat
unlik
predict
simpl
latitudedepend
manner
chang
vector
distribut
exampl
incurs
aed
albopictu
torr
strait
northern
australia
like
lead
perman
colon
mosquito
capac
spread
suit
virus
west
nile
viru
wnv
yellow
fever
viru
st
loui
enceph
dengu
fever
chikungunya
viru
chikv
higher
latitud
irrespect
whether
chang
relat
climat
chang
rapid
adapt
mosquito
cooler
climat
adapt
virus
new
vector
need
continu
adapt
diagnost
method
evid
extrem
climat
event
flood
impact
local
diseas
incid
moreov
flood
provid
water
corridor
distribut
insect
vector
larg
distanc
anthropogen
chang
physic
environ
impact
arboviru
distribut
frequenc
arbovirusrel
ill
exampl
chang
water
tank
usag
propos
major
effect
distribut
dengu
fever
australia
sinc
earli
centuri
russel
colleagu
point
although
current
rang
aed
aegypti
restrict
queensland
histor
distribut
wider
vector
viru
formerli
distribut
across
australia
return
previou
distribut
dengu
could
occur
result
factor
climat
chang
eg
chang
water
manag
vectorcontrol
program
irrig
deforest
major
impact
occurr
epidem
rift
valley
fever
africa
urban
asia
impact
dengu
outbreak
gould
colleagu
provid
comprehens
review
rang
zoonot
arbovirus
western
europ
strong
serolog
evid
wnv
usutu
sindbi
viru
alreadi
circul
uk
author
conclud
climat
chang
probabl
import
requir
emerg
arthropodborn
diseas
dengu
fever
yellow
fever
rift
valley
fever
japanes
enceph
blue
tongu
uk
howev
unavail
reservoir
also
limit
factor
eg
natur
reservoir
yellow
fever
viru
yfv
treedwel
monkey
associ
mosquito
one
unexpect
consequ
global
attempt
control
ae
aegypti
appear
progress
displac
ae
aegypti
aed
albopictu
asian
tiger
mosquito
global
spread
ae
albopictu
also
facilit
tyre
shipment
ae
albopictu
establish
tropic
subtrop
temper
region
ae
albopictu
continu
spread
distribut
dengu
chikungunya
virus
chang
new
diagnost
test
need
anticip
develop
mosquitoborn
flavivirus
propens
adapt
new
mosquito
host
possess
potenti
emerg
area
inhabit
new
host
wnv
isol
mosquito
speci
north
america
wnv
yfv
st
loui
enceph
viru
slev
also
isol
tick
indic
vector
promiscu
chikv
appear
acquir
mutat
envelop
improv
transmiss
compet
ae
albopictu
adapt
postul
facilit
epidem
northern
itali
may
facilit
outbreak
la
reunion
ae
aegypti
long
consid
natur
effect
vector
chikv
human
mosquito
speci
yet
becom
establish
signific
vector
chikv
either
itali
la
reunion
ae
albopictu
gradual
dispers
worldwid
present
activ
itali
la
reunion
consid
effect
vector
chikv
viru
mutat
protein
improv
vector
compet
ae
albopictu
chikv
mutat
appear
arisen
sever
independ
occas
chikv
differ
geograph
region
impli
converg
evolut
presum
select
pressur
tiger
mosquito
de
lamballeri
et
al
describ
three
distinct
exampl
converg
evolut
identifi
approxim
period
identifi
region
la
reunionmauritiusmadagascar
india
cover
italian
viru
introduc
india
cameroon
gabon
popul
ae
albopictu
florida
usa
abl
transmit
chikv
thu
diagnost
test
panel
expand
includ
pathogen
facilit
differenti
relat
alphavirus
circul
america
moreov
rapid
precis
diagnosi
would
increas
likelihood
identifi
associ
vector
speci
would
advantag
new
diagnost
test
could
incorpor
detect
mutat
predictor
rel
eas
transmiss
region
outsid
rang
ae
aegypti
arriv
chikvinfect
travel
india
itali
trigger
outbreak
case
chikungunya
fever
dengu
fever
outbreak
australia
date
seed
infect
travel
exampl
dengu
viru
serotyp
circul
queensland
outbreak
import
australian
travel
return
indonesia
eleg
studi
emerg
spread
drug
resist
meijer
colleagu
monitor
westtoeast
movement
across
europ
influenza
viru
season
increas
frequenc
distribut
oseltamivir
resist
due
mutat
neuraminidas
gene
segment
monitor
period
fit
oseltamivirresist
viru
attribut
occurr
mutat
new
genet
background
provid
drift
variant
oseltamivirresist
viru
estim
dispers
across
europ
longitud
per
week
latitud
correspond
km
per
day
rate
consist
human
travel
movement
anim
host
vector
chang
pathogen
distribut
bat
host
wide
rang
zoonot
agent
includ
lyssa
hendra
nipah
sarslik
corona
marburg
ebola
japanes
enceph
viru
jev
kyasanur
forest
diseas
viru
astrovirus
wnv
australian
bat
lyssaviru
contemporan
emerg
sever
zoonot
virus
last
two
decad
transmiss
virus
human
facilit
bidirect
habitat
encroach
increas
frequenc
contact
bat
human
sometim
involv
intermedi
domest
anim
host
eg
pig
case
nipah
viru
hors
case
hendra
viru
civet
case
sar
satellit
telemetri
demonstr
bat
travel
long
distanc
eg
australia
papua
new
guinea
bird
play
role
dispers
arbovirus
sindbi
viru
slev
wnv
usutu
viru
usuv
usuv
hitherto
found
africa
emerg
vienna
associ
largescal
death
bird
initi
incorrectli
suspect
outbreak
wnv
enceph
see
later
rare
zoonos
exhibit
extrem
virul
human
herp
b
viru
herpesviru
simia
case
point
human
surviv
rate
patient
die
within
week
sever
human
herpesvirus
cytomegaloviru
cmv
varicellazost
viru
vzv
herp
simplex
implic
retin
retinopathi
similar
present
prompt
differenti
diagnosi
vesicular
lesion
crucial
case
herp
b
viru
routin
includ
standard
suit
target
multiplex
realtim
pcrbase
herp
diagnost
would
miss
assay
depend
targetfocus
probe
primat
origin
hiv
well
establish
recent
studi
provid
evid
frequent
regular
transmiss
retrovirus
captiv
wild
anim
expos
human
three
new
primat
retrovirus
simian
foami
viru
identifi
human
expos
blood
bodi
fluid
primat
either
laboratori
contact
hunt
keep
wild
pet
regular
transmiss
primat
human
suggest
viral
adapt
new
host
play
import
role
crossspeci
transmiss
largescal
emerg
human
find
import
implic
design
diagnost
test
employ
public
health
surveil
difficulti
predict
retroviru
emerg
futur
human
virus
exist
quasispeci
infect
human
anim
host
divers
popul
viral
nucleic
acid
sequenc
raw
materi
rapid
evolut
rna
virus
includ
retrovirus
much
higher
mutat
rate
dna
virus
increas
complex
gener
effect
probe
nucleic
acid
amplif
test
result
assay
drop
problem
influenza
diagnost
target
hemagglutinin
ha
neuraminidas
na
segment
exemplifi
necess
ad
hoc
test
develop
human
influenza
swine
origin
swine
influenza
viru
realtim
detect
panel
author
emerg
use
us
fda
test
subsequ
replac
improv
version
develop
cdc
specimen
becam
avail
problem
drop
continu
plagu
commerci
inhous
assay
whiley
colleagu
cite
sever
exampl
pcr
reversetranscriptas
rt
pcrbase
viru
diagnost
assay
prone
falseneg
result
caus
sequenc
variat
list
includ
commerci
assay
human
parvoviru
inhous
method
rabi
cytomegaloviru
call
astut
primer
design
use
multipl
gene
target
within
singl
organ
eg
combin
pcr
por
ctr
gene
neisseria
meningitidi
ha
na
gene
influenza
detect
challeng
design
influenza
diagnost
test
challeng
face
design
influenza
vaccin
vaccin
need
reformul
annual
account
antigen
drift
also
antigen
shift
detect
mutat
reassort
recombin
confer
select
advantag
viru
might
result
resist
antivir
drug
evas
host
immun
respons
increas
replic
effici
surviv
new
host
speci
recent
italian
outbreak
wnv
acquir
mutat
protein
associ
avian
virul
human
outbreak
mutat
predict
increas
high
temperatur
stabil
wnv
helicas
virus
eg
influenza
viru
molecular
signatur
associ
clinic
import
phenotyp
well
character
could
incorpor
firstlin
diagnost
test
provid
critic
time
inform
host
prefer
pathogen
drug
resist
recombin
report
wide
rang
homolog
rna
virus
includ
picornavirus
alphavirus
gb
viru
chepat
g
viru
hepat
c
viru
jev
evid
recombin
found
recombin
wnv
yfv
tickborn
enceph
viru
tbev
slev
recombin
discuss
literatur
potenti
impact
viru
emerg
pathogen
evolut
vaccin
efficaci
implic
safeti
live
vaccin
diagnost
point
view
consid
potenti
sourc
drop
targetfocus
test
particularli
use
pcr
primer
realtim
probe
exact
match
target
sequenc
west
nile
viru
appear
first
time
america
august
within
year
caus
approxim
case
neuroinvas
diseas
north
america
alon
fatal
rate
among
clinic
appar
encephalit
case
wnv
outbreak
record
bird
hors
human
europ
russia
sinc
recent
record
outbreak
itali
report
mani
year
chikv
regard
african
viru
caus
occasion
local
outbreak
human
commun
close
associ
forest
region
viru
circul
among
aed
spp
prior
viru
also
spasmod
associ
outbreak
chikungunya
fever
india
viru
appear
first
time
la
comoro
island
quickli
becam
establish
epidem
endem
subsequ
dispers
india
mani
part
malaysia
epidem
common
involv
million
human
annual
first
time
viru
also
recent
caus
epidem
itali
thu
chikv
endemicepidem
southern
ocean
asia
appear
move
southern
europ
usuv
detect
first
time
vienna
caus
fatal
enceph
wild
bird
viru
detect
sever
southern
european
countri
identifi
etiolog
agent
case
human
neuroinvas
diseas
bluetongu
viru
btv
endem
southern
europ
arriv
first
time
northern
europ
inde
btv
cross
english
channel
caus
outbreak
uk
control
use
combin
quarantin
control
import
measur
vaccin
usag
time
write
btv
reappear
uk
crimeancongo
hemorrhag
fever
recent
occur
first
time
southern
europ
rift
valley
fever
two
occas
move
africa
arabian
peninsula
sinc
discoveri
hendra
viru
australia
nipah
viru
case
hemorrhag
fever
due
one
virus
south
america
dengu
viru
expand
rang
argentina
septemb
two
independ
case
autochthon
transmiss
dengu
fever
two
chikungunya
fever
occur
southeastern
franc
clearli
event
implic
europ
consequ
innov
rapid
design
nucleic
acidbas
viru
diagnost
implic
emerg
diseas
environ
design
diagnost
test
moderngener
diagnost
test
must
readili
adapt
capabl
detect
identifi
known
unknown
even
variant
novel
virus
field
sampl
fundament
three
level
categori
diagnosi
base
level
confid
hypothes
regard
etiolog
agent
specif
ident
etiolog
agent
ident
etiolog
agent
suspect
level
genu
famili
group
agent
caus
enceph
hemorrhag
fever
respiratori
infect
ident
etiolog
agent
complet
unknown
first
scenario
diagnosi
could
potenti
carri
via
tool
incorpor
target
multiplex
realtim
suit
target
multiplex
pcrmicrospher
panel
second
scenario
diagnosi
could
potenti
carri
via
tool
incorpor
degener
pcr
eg
target
genu
level
follow
simpl
microspher
mass
spectrometri
third
scenario
focus
assay
fail
diagnosi
could
potenti
carri
via
tool
incorpor
random
arraybas
detect
realtim
pcr
rapidli
becom
favor
method
choic
clinic
virolog
laboratori
routin
use
targetfocus
test
mani
virus
includ
parvoviru
btv
wnv
dengu
viru
influenza
viru
influenza
b
viru
least
eight
human
herp
virus
multiplex
util
test
enabl
coamplif
intern
extern
control
along
target
viral
nucleic
acid
eg
well
reason
economi
work
flow
includ
sever
detect
target
one
two
reaction
tube
level
multiplex
increas
variou
strategi
one
method
util
entail
divid
extract
nucleic
acid
sampl
one
tube
use
sequenti
realtim
reaction
posit
reaction
identifi
meltcurv
analysi
one
tube
mean
prove
possibl
detect
differenti
vzv
viru
ebv
cmv
human
herp
viru
hhv
mention
earlier
rarer
yet
highli
pathogen
herp
virus
eg
herp
simia
viru
includ
panel
mani
multiplex
realtim
pcr
assay
depend
multipl
exactmatch
primer
direct
singl
target
gene
vulner
sequenc
variat
dropout
signal
anoth
strategi
increas
level
multiplex
util
gcrich
extens
tail
pcr
primer
allow
discrimin
amplifi
target
meltcurv
analysi
lo
et
al
use
approach
combin
use
two
fluorophor
intercal
dye
green
use
hybrid
strategi
author
abl
detect
differenti
dengu
viru
serotyp
howev
assay
design
detect
jev
cocircul
dengu
mani
locat
asia
targetfocus
approach
use
identifi
one
candid
panel
virus
microspheresmicrobead
microspher
enabl
captur
spatial
separ
pcr
product
product
address
via
uniqu
correspond
oligonucleotid
captur
sequenc
microspher
color
microspher
three
commerci
avail
respiratori
viru
panel
reli
target
multiplex
pcr
resplex
ii
qiagen
eragen
bioscienc
luminex
balada
llasat
et
al
recent
evalu
three
system
respiratori
panel
develop
mahoni
et
al
detect
human
respiratori
virus
viru
subtyp
commerci
avail
luminex
xtag
system
reli
multiplex
pcr
use
virusspecif
primer
follow
captur
oligonucleotid
tag
pcr
product
onto
univers
oligonucleotoid
tag
microspher
follow
targetspecif
primer
extens
phycoerythrin
label
incorpor
extens
product
microspher
pass
flow
cell
signal
detect
red
laser
identifi
microspher
green
laser
measur
phycoerythrin
local
microspher
list
detect
virus
includ
influenza
subtyp
influenza
b
respiratori
syncyti
viru
b
metapneumoviru
rhinoviru
parainfluenza
sever
acut
respiratori
syndromeassoci
coronaviru
four
coronavirus
adenovirus
unspecifi
type
nolt
colleagu
contemporan
develop
similar
system
util
modifi
nucleotid
label
microspherecaptur
primer
extens
product
latter
system
commerci
avail
multicodeplx
design
detect
respiratori
virus
three
commerci
avail
multiplex
pcr
panel
exhibit
superior
sensit
compar
viru
cultur
method
although
system
cast
rel
broad
net
targetfocus
use
targetspecif
primer
therefor
suscept
drop
failur
detect
variant
virus
illustr
point
xtag
respiratori
viru
panel
addit
detect
influenza
identifi
subtyp
season
influenza
howev
subtyp
novel
influenza
viru
swine
origin
outbreak
could
identifi
emerg
untyp
influenza
viru
use
xtag
panel
cleverli
turn
neg
posit
test
ginochio
st
georg
demonstr
untyp
influenza
viru
least
outbreak
statist
like
robust
diagnost
solut
eg
redesign
xtag
panel
need
futur
chang
subtyp
preval
invalid
conclus
ginocchio
et
al
also
compar
xtag
system
influenza
b
test
inver
medic
intern
cranfield
uk
rapid
detect
flu
b
test
st
paul
mn
usa
antigendetect
test
xtag
panel
demonstr
far
superior
sensit
infer
detect
novel
influenza
swine
origin
ie
detect
influenza
viru
untyp
use
xtag
panel
howev
xtag
respiratori
viru
panel
modifi
allow
unambigu
subtyp
influenza
viru
order
confirm
provision
comparison
test
exampl
serv
demonstr
type
problem
aris
develop
diagnost
test
design
identifi
specif
virus
rtpcr
interfac
prototyp
array
detect
system
util
novel
probe
design
dichot
binari
probe
success
divid
target
popul
sequenc
two
popul
react
probe
figur
probe
gener
yesno
binari
answer
describ
term
base
logarithm
x
number
probe
maximum
number
speci
differenti
exampl
ten
probe
differenti
speci
probe
differenti
million
system
gener
binari
barcod
discoveri
new
nonzero
barcod
flag
new
relat
viru
exampl
one
compar
binari
barcod
two
virus
dichot
array
consist
nine
spot
differ
code
interpret
reveal
three
region
similar
one
region
nonsimilar
two
virus
type
array
detect
yield
immedi
expand
test
newli
discov
virus
gener
new
barcod
exist
array
new
barcod
enter
patternmatch
databas
new
test
rapidli
avail
arraybas
nontargetfocus
detect
method
exampl
adapt
diagnost
test
wang
et
al
demonstr
nucleic
acid
recov
array
use
detail
character
new
virus
moureau
et
al
also
develop
onestep
rtpcr
method
univers
correctli
pangenu
detect
flavivirus
primer
modif
degener
primer
describ
earlier
assay
extend
develop
realtim
rtpcr
version
test
use
sybr
green
system
realtim
assay
posit
follow
direct
sequenc
use
amplif
primer
test
exhibit
exquisit
sensit
notabl
capabl
detect
cell
fuse
agent
viru
mosquito
pool
ngoy
viru
crush
tick
protocol
mahersturgess
et
al
moureau
et
al
avoid
use
nest
pcr
featur
mani
earlier
assay
prone
contamin
previous
found
africa
usuv
appear
vienna
austria
associ
extens
bird
mortal
led
presumpt
diagnosi
wnv
although
serolog
histochemistri
posit
wnv
sampl
neg
targetfocus
west
nile
viru
pcr
accordingli
univers
rtpcr
develop
use
degener
primer
base
sequenc
sever
mosquitoborn
flavirus
use
new
rtpcr
target
region
follow
sequenc
led
identif
usuv
similarli
case
neuroinvas
infect
molecular
test
cerebrospin
fluid
neg
cmv
ebv
adenovirus
parvoviru
wnv
use
heminest
degener
pcr
genu
flaviviru
necessari
amplifi
viru
enabl
subsequ
identif
usuv
direct
sequenc
expans
arboviru
surveil
report
system
implement
north
america
follow
appear
wnv
arbonet
collect
report
data
human
mosquito
bird
mammal
sentinel
chicken
data
integr
singl
report
system
similar
surveil
expans
taken
place
europ
wnv
usuv
outbreak
broadspectrum
molecular
test
previous
describ
make
signific
contribut
program
influenza
viru
possess
molecular
signatur
determin
host
prefer
pathogen
potenti
drug
resist
signatur
locat
ha
gene
segment
gene
segment
na
gene
segment
gene
segment
although
associ
signatur
phenotyp
well
establish
signatur
yet
util
frontlin
diagnost
test
current
give
littl
rudimentari
inform
ha
na
type
respons
need
castillo
alvarez
et
al
develop
degener
primer
singlestep
touchdown
rtpcr
detect
na
subtyp
amplifi
region
na
gene
segment
contain
molecular
signatur
encod
oseltamivir
resist
segment
influenza
subtyp
contain
molecular
signatur
pathogen
second
weak
current
frontlin
diagnost
test
commerci
inhous
assay
target
limit
rang
ha
na
type
moreov
prone
drop
due
sequenc
variat
primer
probe
region
respons
problem
robust
albeit
targetfocus
realtim
rtpcr
develop
detect
swine
origin
improv
use
rtpcr
amplifi
two
gene
segment
ha
na
gene
assay
detect
first
case
novel
influenza
australia
fischer
et
al
also
util
univers
pcr
flavirus
first
phase
symmetr
pcr
follow
second
round
asymmetr
pcr
follow
captur
pcr
product
onto
luminex
bead
preconjug
primer
specif
flavirus
four
alphavirus
detect
assay
show
better
sensiv
pcr
kunjin
japanes
enceph
virus
disadvantag
type
microspher
panel
disadvantag
share
respiratori
viru
panel
discuss
previous
typic
contain
one
virusspecif
probe
per
viru
render
suscept
drop
event
sequenc
chang
speci
genu
alphaviru
mani
subtyp
intract
challeng
targetfocus
diagnost
eshoo
et
al
develop
multilocu
broadspectrum
rtpcr
util
degener
oligonucleotid
primer
follow
electrospray
ioniz
mass
spectrometri
esim
identifi
alphavirus
base
composit
small
set
mixedbas
primer
pair
target
conserv
site
alphaviru
rna
genom
base
composit
amplicon
could
unambigu
assign
speci
subtyp
isol
old
new
world
alphavirus
assay
use
detect
alphavirus
natur
occur
mosquito
vector
collect
locat
south
america
asia
one
mosquito
pool
peru
contain
alphaviru
distinct
mass
spectrum
signatur
subsequ
sequenc
confirm
viru
member
new
subtyp
mucambo
viru
speci
subtyp
iiid
venezuelan
equin
enceph
viru
complex
highthroughput
assay
use
surveil
discoveri
uncharacter
emerg
virus
road
incorpor
metagenom
clinic
virolog
lab
may
smooth
combin
random
amplif
strategi
dens
tile
array
dichot
array
see
earlier
wang
et
al
combin
random
prime
ab
pcr
protocol
dens
tile
array
contain
highli
conserv
sequenc
everi
fulli
sequenc
genom
genbank
mean
rapid
identif
patternmatch
possibl
novel
virus
discov
simpli
scrape
hybrid
viral
sequenc
array
novel
coronaviru
discov
method
although
pathogen
array
proven
util
discov
novel
virus
technic
problem
relat
accuraci
sensit
result
resist
use
routin
patient
care
wong
et
al
demonstr
amplif
effici
random
primer
crucial
determin
probe
hybrid
signal
develop
algorithm
predict
random
prime
viral
amplif
effici
score
order
correl
predict
viru
amplif
effici
score
array
hybrid
signal
util
nimblegen
array
synthesi
technolog
detect
rna
virus
use
probe
tile
across
full
length
viru
genom
probe
includ
replic
probe
control
predict
algorithm
use
design
amplif
effici
score
optim
primer
highest
score
virus
repres
array
util
optim
amplif
microarray
platform
identifi
pathogen
sensit
specif
rel
realtim
pcr
combimatrix
corpor
develop
sequenc
microarray
includ
broadscan
microarray
subtyp
influenza
viru
system
technolog
eleg
howev
multiplex
rtpcr
amplif
influenza
viru
nucleic
acid
prior
hybrid
depend
use
targetspecif
revers
primer
moreov
probe
array
uniqu
target
subtyp
configur
mean
system
potenti
vulner
drop
need
redesign
new
subtyp
aris
mutat
aris
region
viru
recogn
primer
probe
bolotin
et
al
evalu
combimatrix
influenza
detect
system
compar
fdaapprov
luminex
respiratori
viru
panel
see
earlier
subtyp
influenza
viru
although
limit
detect
combimatrix
test
three
order
magnitud
greater
respiratori
syncyti
viru
panel
sensit
detect
either
season
influenza
virus
still
rel
luminex
respiratori
viru
panel
core
element
biosensor
amplif
detect
technolog
may
built
use
nanotechnolog
howev
assay
design
remain
fundament
challeng
emerg
diseas
environ
met
sensit
specif
use
multipl
target
gene
avoid
drop
capabl
detect
unexpect
novel
virus
rang
new
detect
technolog
emerg
last
decad
one
make
impact
compat
assay
design
support
high
degre
multiplex
adapt
detect
new
virus
adapt
resid
astut
primer
design
use
new
bioinformat
approach
see
earlier
high
degre
multiplex
turn
depend
resolut
signal
simultan
assay
either
detect
differ
energi
frequenc
spatiallytempor
resolv
signal
one
two
three
four
dimens
azzazi
et
al
review
core
technolog
nanodiagnost
compar
quantum
dot
cantilev
nanoparticl
quantum
dot
nanoparticlebas
assay
offer
potenti
largescal
multiplex
nucleic
acidbas
diagnost
test
gener
via
use
captur
oligonucleotid
address
separ
reaction
analysi
nucleic
acid
amplif
microspher
core
technolog
newgener
sequenc
yet
fulli
exploit
firstlin
clinic
molecular
diagnost
frontier
research
address
realtim
nucleic
acid
test
potenti
use
microspher
platform
need
interfac
technolog
akin
use
sequenc
allow
continu
read
fluoresc
signal
develop
microspher
one
system
develop
realtim
pcr
reaction
carri
microspher
substrat
micropl
nanowir
see
later
use
larg
set
oligonucleotid
sequenc
tag
oligonucleotid
tag
one
set
microspher
adapt
perform
mani
differ
realtim
assay
close
selfcontain
fulli
integr
autom
platform
combin
onboard
sampl
prepar
realtim
pcr
fluoresc
detect
avail
rang
targetfocus
realtim
pcrbase
diagnost
test
one
assay
develop
type
fulli
integr
platform
influenza
diagnost
tool
detect
distinguish
excel
sensit
specif
season
influenza
influenza
b
novel
influenza
howev
independ
effici
hardwar
use
execut
test
assay
design
remain
key
issu
type
targetfocus
assay
next
season
preval
strain
influenza
viru
may
chang
necessit
redesign
assay
renegoti
regulatori
process
although
sophist
assay
design
increas
breadth
analyt
detect
realtim
assay
use
extens
pcr
primer
meltcurv
analysi
fluoresc
system
depend
label
remain
limit
number
optic
detect
channel
therefor
limit
number
target
analyt
select
necessit
redesign
accommod
emerg
novel
recombin
reassort
genet
variant
nanowir
may
overcom
challeng
multiplex
label
requir
limit
number
avail
label
wire
less
nm
wide
may
coat
coval
link
oligonucleotid
nanowir
array
nucleic
acid
amplifi
hybrid
nanowir
result
direct
convers
hybrid
event
electr
signal
direct
interfac
inform
system
stern
colleagu
develop
nanowir
complementari
metal
oxid
semiconductorbas
labelfre
immunodetect
avoid
problem
deby
screen
salt
concentr
buffer
use
macromolecular
sens
experi
must
chosen
deby
distanc
suffici
long
enabl
sens
suffici
short
screen
unbound
macromolecul
other
develop
etch
siliconbas
nanowir
sensor
direct
measur
nucleic
acid
hybrid
bunimovich
et
al
demonstr
singlestrand
complementari
oligonucleotid
abl
significantli
chang
conduct
group
silicon
nanowir
solut
hybrid
primari
dna
strand
electrostat
adsorb
onto
aminetermin
organ
monolay
nanowir
intim
contact
primari
strand
amin
group
nanowir
surfac
bring
bind
event
within
deby
distanc
allow
bind
event
electron
detect
moreov
within
ionic
strength
solut
dna
hybrid
effici
compar
solut
lower
ionic
strength
work
lead
multichannel
devic
capabl
high
degre
multiplex
system
interfac
set
univers
captur
oligonucleotid
coat
coval
link
onto
nanowir
becom
highli
parallel
rapidli
adapt
diagnost
system
longerterm
vision
devic
integr
amplif
use
nanowir
chip
drop
pcr
tube
relay
electr
signal
via
radiofrequ
identif
devic
remot
locat
central
server
figur
evid
rise
techniqu
random
pcr
unbias
newgener
sequenc
pathogen
detect
microarray
viru
diagnosi
viru
discoveri
method
continu
develop
synergist
discoveri
new
hybrid
pattern
microarray
translat
quickli
diagnost
test
novel
viru
metagenom
transform
abil
discov
virus
yet
wide
use
clinic
diagnost
laboratori
howev
alert
us
potenti
stagger
viral
divers
exist
increasingli
inform
design
assay
immedi
suitabl
use
clinic
eg
multiplex
realtim
pcr
microspherebas
viru
diagnost
panel
combin
random
amplif
pcr
array
either
broadspectrum
convent
design
array
simpl
power
array
design
use
innov
bioinformat
new
hardwar
platform
increas
diagnost
capac
abil
laboratori
detect
unexpect
virus
drive
multiplex
driven
desir
increas
diagnost
capac
reduc
cost
technolog
design
strategi
improv
multiplex
assay
achiev
compar
sensit
parent
monoplex
assay
limit
realtim
pcr
use
exist
technolog
restrict
multiplex
impos
limit
number
avail
fluorophor
separ
spectra
howev
number
detect
simultan
target
broaden
intellig
primer
design
use
tail
pcr
product
allow
differenti
size
melt
curv
split
sampl
multipl
reaction
second
pervas
restrict
limit
targetfocus
amplif
hybrid
nucleic
acid
test
possibl
drop
target
sequenc
evolv
novel
variant
emerg
continu
plagu
commerci
inhous
assay
necessit
astut
primer
design
use
multipl
gene
target
within
singl
organ
emerg
diseas
environ
within
target
multiplex
need
gener
adopt
thu
pressur
increas
multiplex
result
two
requir
first
need
increas
number
gene
target
within
singl
viru
second
need
increas
number
differ
virus
detect
singl
assay
current
frontlin
viru
diagnost
test
take
account
molecular
signatur
carri
import
inform
regard
host
prefer
pathogen
drug
resist
case
influenza
viru
good
understand
molecular
basi
host
prefer
avian
versu
human
high
low
pathogen
mutat
ha
segment
drug
resist
incorpor
capac
detect
signatur
technic
feasibl
would
allow
public
health
respons
rapidli
inform
molecular
signatur
addit
public
health
statist
morbid
mortal
proven
unreli
countri
novel
influenza
virus
emerg
emerg
diseas
environ
technolog
requir
enabl
detect
unanticip
pathogen
surpris
emerg
usuv
wnv
chikv
temper
region
salutori
event
rapid
emerg
drugresist
influenza
viru
europ
season
technolog
rapidli
adapt
impervi
viru
evolut
informationrich
crucial
respond
time
inform
manner
surpris
avoid
need
de
novo
assay
design
sequenti
assay
grow
trend
toward
highli
multiplex
assay
infecti
agent
use
spatial
address
reaction
chip
micropl
microspher
nanowir
earli
exampl
emerg
trend
microspherebas
respiratori
panel
distant
horizon
may
see
emerg
highli
multiplex
realtim
pcr
assay
microspher
array
would
offer
broadspectrum
pcr
multiplex
microspher
detect
combin
quantif
inde
realtim
detect
technolog
alreadi
develop
use
microspher
platform
next
year
new
devic
enter
market
facilit
diagnost
test
pointofcar
pcr
field
pathogen
detect
array
develop
combin
nucleic
acid
extract
captur
nucleic
acid
onto
array
onboard
newgener
sequenc
integr
new
platform
appropri
oligonucleotid
primer
design
suffici
flexibl
detect
emerg
andor
variant
virus
chang
face
diagnost
take
discoveri
tool
clinic
provid
detail
inform
better
known
pathogen
highthroughput
unbias
sequenc
becom
cheaper
see
increas
applic
techniqu
diagnost
tool
use
absenc
priori
assumpt
base
presumpt
diagnosi
becom
realiti
medic
veterinari
ecolog
signific
newli
discov
virus
diseas
need
elucid
one
visual
discoverydriven
increas
research
biolog
pathogenesi
epidemiolog
emerg
virus
evid
diagnost
virolog
excit
futur
